Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
Allergic Reactions02:06

Allergic Reactions

Overview
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
Hypersensitivities01:30

Hypersensitivities

Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Hypersensitivity Reactions: Immune-Complex Reactions01:19

Hypersensitivity Reactions: Immune-Complex Reactions

Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From legacy subsets to auditable descriptors: implementing the 2025 T-cell nomenclature guidelines for inflammatory skin diseases.

The British journal of dermatology·2026
Same author

Absolute Eczema Area and Severity Index Responses with Lebrikizumab in Patients with Moderate-to-severe Atopic Dermatitis: A Secondary Analysis of Two Phase 3 Trials.

Acta dermato-venereologica·2026
Same author

The definition of response and inadequate response to topical corticosteroid treatment in atopic dermatitis and related skin inflammatory diseases: A GA<sup>2</sup>LEN ADCARE statement paper.

The World Allergy Organization journal·2026
Same author

Transforming growth factor β induced as a novel secreted immune checkpoint counterinhibiting human tumor-associated T cells.

Journal for immunotherapy of cancer·2026
Same author

Hailey-Hailey disease exhibits a mixed type 2/type 3 molecular signature but shows a therapeutic response to type 2 inhibitors.

European journal of dermatology : EJD·2026
Same author

Integrated Clinical Trial and Molecular Profiling Reveals Immune Drivers of Chronic Hand Eczema.

Allergy·2026

Related Experiment Video

Updated: Jun 23, 2026

A Mouse Ear Model for Allergic Contact Dermatitis Evaluation
08:02

A Mouse Ear Model for Allergic Contact Dermatitis Evaluation

Published on: March 24, 2023

Allergic and irritant contact dermatitis.

Audrey Nosbaum1, Marc Vocanson, Aurore Rozieres

  • 1Université Lyon 1, UFR Lyon-Sud Charles Mérieux; UF Allergologie et Immunologie Clinique, CH Lyon-Sud; INSERM U 851, IFR 128 Biosciences Lyon-Sud/Gerland.

European Journal of Dermatology : EJD
|May 19, 2009
PubMed
Summary

Irritant and allergic contact dermatitis are common skin conditions. Detecting antigen-specific T cells using enzyme-linked immunospot assay (ELISPOT) aids in diagnosing allergic contact dermatitis.

More Related Videos

Contact Hypersensitivity as a Murine Model of Allergic Contact Dermatitis
08:25

Contact Hypersensitivity as a Murine Model of Allergic Contact Dermatitis

Published on: September 26, 2022

An In Vitro Skin Irritation Test (SIT) using the EpiDerm Reconstructed Human Epidermal (RHE) Model
21:16

An In Vitro Skin Irritation Test (SIT) using the EpiDerm Reconstructed Human Epidermal (RHE) Model

Published on: July 13, 2009

Related Experiment Videos

Last Updated: Jun 23, 2026

A Mouse Ear Model for Allergic Contact Dermatitis Evaluation
08:02

A Mouse Ear Model for Allergic Contact Dermatitis Evaluation

Published on: March 24, 2023

Contact Hypersensitivity as a Murine Model of Allergic Contact Dermatitis
08:25

Contact Hypersensitivity as a Murine Model of Allergic Contact Dermatitis

Published on: September 26, 2022

An In Vitro Skin Irritation Test (SIT) using the EpiDerm Reconstructed Human Epidermal (RHE) Model
21:16

An In Vitro Skin Irritation Test (SIT) using the EpiDerm Reconstructed Human Epidermal (RHE) Model

Published on: July 13, 2009

Area of Science:

  • Immunodermatology
  • Toxicology
  • Cellular Immunology

Background:

  • Irritant contact dermatitis (ICD) and allergic contact dermatitis (ACD) are common inflammatory skin conditions caused by chemical exposure.
  • ICD involves innate immune activation, while ACD is a T-cell mediated delayed-type hypersensitivity response.
  • Recent research highlights the association between ICD and ACD, suggesting ICD prevention is key for ACD management.

Purpose of the Study:

  • To differentiate between ICD and ACD based on pathophysiological mechanisms.
  • To explore immunological diagnostic methods for distinguishing ICD from ACD.
  • To evaluate the utility of T-cell detection, specifically ELISPOT, for ACD diagnosis.

Main Methods:

  • Review of pathophysiological mechanisms underlying ICD and ACD.
  • Discussion of immunological diagnostic approaches, focusing on T-cell detection.
  • Highlighting the enzyme-linked immunospot assay (ELISPOT) for detecting hapten-specific T cells.

Main Results:

  • ICD and ACD, though clinically similar, have distinct pathophysiological pathways.
  • The presence of antigen-specific T cells is indicative of ACD, while their absence suggests ICD.
  • ELISPOT assay shows promise as a tool for the immunobiological diagnosis of ACD, particularly in metal allergies.

Conclusions:

  • Distinguishing ICD and ACD is crucial for effective management and prevention strategies.
  • Immunological diagnosis, particularly T-cell detection via ELISPOT, offers a biological basis for differentiating ACD from ICD.
  • ELISPOT assay represents a significant advancement in diagnosing ACD, offering a valuable tool for clinical and research settings.